ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: 2157 • 2012 ACR/ARHP Annual Meeting

    Resveratrol Counters Pro-Atherogenic Effects of Systemic Lupus Erythematosus and Rheumatoid Arthritis Plasma On Cholesterol Efflux in Human Macrophages

    Allison B. Reiss1, Iryna Voloshyna1, Ofek Hai1, Michael J. Littlefield1, Elise Belilos2, Kristina B. Belostocki2, Lois A. Bonetti3, Gary C. Rosenblum2 and Steven E. Carsons4, 1Medicine, Winthrop University Hospital, Mineola, NY, 2Rheumatology, Winthrop University Hospital, Mineola, NY, 3Rheum & Immun, Winthrop University Hospital, Mineola, NY, 4Div of Rheumatology, Winthrop University Hospital, Mineola, NY

    Background/Purpose: Our group has demonstrated that resveratrol, a plant polyphenol, possesses atheroprotective properties, enhancing expression of reverse cholesterol transport (RCT) proteins. We have reported that Systemic…
  • Abstract Number: 1800 • 2012 ACR/ARHP Annual Meeting

    Macrophages in Hypoxic Rheumatoid Joints Preferentially Express Hypoxia Inducible Transcription Factor-2

    Sarah Aynsley1, Ursula Fearon2, Anthony G. Wilson1 and Munitta Muthana3, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 3Infection and Immunity, University of sheffield, Sheffield, United Kingdom

    Background/Purpose: In rheumatoid arthritis (RA), the influx of inflammatory cells as well as the aggressive proliferation of fibroblast-like synovial cells (FLS) outstrips the oxygen supply…
  • Abstract Number: 1801 • 2012 ACR/ARHP Annual Meeting

    Biological Roles of C5orf30 in Rheumatoid Arthritis

    Munitta Muthana1, Sachin Khetan2, Gbadebo Adeleke Adeleke3, Simon Tazzyman3, Sarah Aynsley1, Fiona Morrow1, Sarah Hawtree1, Barbara Ciani4 and Anthony G. Wilson1, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Infection and immunity, Dr, Sheffield, United Kingdom, 3Infection and Immunity, Dr, Sheffield, United Kingdom, 4Chemistry, University of Sheffield, Sheffield, United Kingdom

    Background/Purpose: A recent genome wide association study identified the variant rs26232 in the first exon of an uncharacterized gene C5orf30. In addition, this variant is…
  • Abstract Number: 1454 • 2012 ACR/ARHP Annual Meeting

    Characterization of Renal Mononuclear Phagocyte Populations in Murine SLE Nephritis

    Ranjit Sahu1, Ramalingam Bethunaickan2 and Anne Davidson1, 1Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY, 2Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Macrophages and dendritic cells contribute to renal damage in chronic renal diseases including lupus nephritis. However owing to their multiple phenotypic and functional variations,…
  • Abstract Number: 1196 • 2012 ACR/ARHP Annual Meeting

    Analysis of Gene Expression Patterns in Rheumatoid  Arthritis (RA) Synovial Macrophages From Patients Undergoing Disease Flare

    Karen L. Berg1, Adedayo Hanidu1, Jon Hill2, Xiaoyu Jiang1, Tom Freeman2, Jennifer Swantek1, Anna Yarlina3, George D. Kalliolias4, Lionel B. Ivashkiv5 and Gerald H. Nabozny1, 1Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 2Scientific Knowledge Discovery, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, 3Hospital for Special Surgery, New York, NY, 4Medicine, Hospital for Special Surgery, New York, NY, 5Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Synovial macrophages play a key role in RA pathogenesis.  Their numbers are greatly increased in RA synovium, their phenotype is consistent with a pro-inflammatory…
  • Abstract Number: 1078 • 2012 ACR/ARHP Annual Meeting

    Prolactin Is Increased in Responders to Anti-TNFá Treatment and the Role of the Prolactin Receptor in Rheumatoid Arthritis

    Man Wai Tang1, Danielle Marie Gerlag2, Veronica Codullo3, Elsa Vieira-Sousa4, Anne Q. Reuwer5, Marcel T. Twickler5, Robert B. M. Landewé6 and Paul Peter Tak7, 1Division of Clinical Immunology and Rheumatology & Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 2Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 3Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 4Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 5Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterddam, Netherlands, 6Academic Medical Center/University of Amsterdam & Atrium Medical Center, Amsterdam, Netherlands, 7Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is the most common rheumatic disease which mainly affects women. In the last decade, it is known that prolactin (PRL) is…
  • Abstract Number: 1057 • 2012 ACR/ARHP Annual Meeting

    A Specific Inhibitor of Spleen Tyrosine Kinase, PRT062607, Is a Potent Modulator of Innate Immune Cell Function

    Lynn A. Kamen1, Gillian Stephens1, Anjali Pandey2 and Uma Sinha1, 1Biology, Portola Pharmaceuticals, South San Francisco, CA, 2Chemistry, Portola Pharmaceuticals, South San Francisco, CA

    Background/Purpose: Tumor Necrosis Factor-α (TNF-α) is an essential component of the inflammatory stimuli leading to rheumatoid arthritis (RA).  Therapeutics targeting TNF-α are the standard of…
  • Abstract Number: 901 • 2012 ACR/ARHP Annual Meeting

    Colony-Stimulating Factor (CSF) Receptor 1 Blockade Overcomes Overlapping Effects of M-CSF and Interleukin-34 On Myeloid Differentiation and Gene Expression to Reduce Inflammation in Human and Murine Models of Rheumatoid Arthritis

    Samuel Garcia1, Linda M. Hartkamp2, Inge E. van Es2, Haishan Lin3, Li Long3, Emma L. Masteller3, Brian R. Wong3, Paul P. Tak4 and Kris A. Reedquist2, 1Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Five Prime Therapeutics, Inc., South San Francisco, CA, 4Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and GlaxoSmithKline, Amsterdam, Netherlands

    Background/Purpose: Disease activity and response to therapy in RA correlates with changes in synovial macrophage numbers and their products. M-CSF or IL-34 stimulation of their…
  • Abstract Number: 880 • 2012 ACR/ARHP Annual Meeting

    Interferon Regulatory Factor 8 Regulates BAFF Production in Murine Macrophages and Is a Nexus for Cross Talk Between IFN-γ and TGF-β

    Weijia Yuan1, Sanjay Gupta2, Jane E. Salmon3 and Alessandra B. Pernis2, 1Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2Autoimmunity & Inflammation, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 3Dept of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

    Background/Purpose: Lupus is a systemic autoimmune disease that can lead to severe end-organ damage characterized by unabated inflammation and aberrant tissue repair. Macrophage dysregulation plays…
  • Abstract Number: 882 • 2012 ACR/ARHP Annual Meeting

    Anti-Inflammatory Effects of Phosphodiesterase 4 Inhibition Are Mediated by Mitogen-Activated Protein Kinase Phosphatase-1

    Riku Korhonen, Tuija Hömmö, Mirka Laavola, Tiina Keränen, Mari Hämäläinen and Eeva Moilanen, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland

    Background/Purpose: MAP kinase phosphatase-1 (MKP-1) is a nuclear tyrosine/threonine phosphatase that limits p38 MAP kinase activity. MKP-1 KO mice display excessive inflammatory response, and exhibit…
  • Abstract Number: 733 • 2012 ACR/ARHP Annual Meeting

    Intra-Articular Injection of Adipose-Derived Stem Cells Inhibits Activation of the Synovium and Protects Against Cartilage Damage and Enthesophyte Formation in Murine Experimental Osteoarthritis

    Peter L.E.M. van Lent1, Menno C. ter Huurne2, Arjen B. Blom3, Rik Schelbergen3, Louis Casteilla4, Thomas Vogl5, Johannes Roth5, Roxane Blattes4, Christian Jorgensen6 and Wim B. van den Berg7, 1Rheumatology Research & Advanced Therpeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4STROMALab UPS/CNRS UMR5273, INSERM U1031, Toulouse, France, 5Institute of Immunology, University of Muenster, Munster, Germany, 6Department of therapy & Immuno-Rhumatology, Hospital Lapeyronie, Montpellier, France, 7Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands

    Background/Purpose: OA lesions are treated with mesenchymal stem cells aiming to enhance tissue repair by transformation to eg. chondrocytes.  Recently it has been shown that…
  • Abstract Number: 666 • 2012 ACR/ARHP Annual Meeting

    Leukadherin 1, a CR3 Mimetic, Negatively Regulates Toll Like Receptor (TLR) Dependent Inflammatory Responses via  Degradation of an Adaptor Protein

    Kristen Lee1, Joanne H. Reed2, Vineet Gupta3, Tejaskumar Patel2, Jill P. Buyon4 and Robert M. Clancy2, 1Rheumatology, NYU Langone Medical Center, New York, NY, 2Medicine, New York University School of Medicine, New York, NY, 3Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miami, FL 33136, U.S.A., Miami, FL, 4Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: Systemic Lupus Erythematosus is characterized by continuous and cyclic stimulation of the innate immune system by endogenous nucleic acids. Immune complexes of Ro60, ssRNA…
  • Abstract Number: 344 • 2012 ACR/ARHP Annual Meeting

    Non Classical Monocytes Are Required for Initiation Phase While Macrophages Are Necessary for the Resolution Phase in the K/BxN Murine of Inflammatory Arthritis

    Alexander V. Misharin1, G. Kenneth Haines III2 and Harris R. Perlman3, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Department of Pathology, Yale University, New Haven, CT, 3Feinberg School of Medicine, Northwestern University, Chicago, IL

    Background/Purpose: Monocytes and macrophages play an essential function in the pathogenesis of rheumatoid arthritis. However, monocytes and macrophages are a heterogenous population and thus the…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology